69.7 F
Pakistan
Thursday, October 8, 2026
HomeHealthFall Clinical 2026: Galderma Presents New Three-Year Nemluvio® Data Showing Deep And...

Fall Clinical 2026: Galderma Presents New Three-Year Nemluvio® Data Showing Deep And Lasting Skin Lesion And Itch Respon…

(MENAFN – AETOSWire) (BUSINESS WIRE )–Galderma (SIX: GALD), the pure-play dermatology category leader, today announced new data regarding the use of Nemluvio for atopic dermatitis and prurigo. ..

Read full story on Menafn

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -
Google search engine

Most Popular

Recent Comments